| 8/29/2013 | CVIG | S&P: Molson view to positive
|
| 7/31/2013 | CV | Molson Coors pays off 2.5% convertibles; any residuals due Sept. 9
|
| 7/8/2013 | CV | Market Commentary: Convertibles firmer; shorter-dated issues holding up; Peabody, longer-dated names weaker
|
| 7/5/2013 | CV | Market Commentary: Convertibles quiet after holiday; 'soft' market eyed after job report pushes rates higher
|
| 7/3/2013 | CV | Market Commentary: Convertibles quiet ahead of July Fourth; some follow-through action in Newmont, Molson
|
| 7/2/2013 | CV | Market Commentary: New Healthways trades around par; Newmont series A adds slightly; Molson slips again
|
| 5/7/2013 | CV | Market Commentary: Molson slips on hedge after earnings; Chiquita flat to lower; Alpha Natural paper on tap
|
| 4/3/2013 | CV | Market Commentary: Planned Liberty upsized, talk revised; deal models rich to slightly cheap; Molson eyed
|
| 4/2/2013 | CV | Market Commentary: Nuance flat to higher on hedge; BGC Partners mostly flat; Intelsat, Liberty launch deals
|
| 4/1/2013 | CV | Market Commentary: Molson Coors active, in line with shares; Prologis trades flat to lower; DFC Global tanks
|
| 11/8/2012 | CV | Market Commentary: New iStar rises, then fades with stock after deal upsizing; Molycorp slips with shares
|
| 10/1/2012 | CV | Market Commentary: Lam Research trades actively; Molson Coors 'in' slightly; WellPoint offers $1.35 billion
|
| 4/27/2012 | CACVIG | DBRS rates Molson notes BBB
|
| 4/26/2012 | CACVIG | S&P: Molson Coors notes BBB-
|
| 4/26/2012 | CACVIG | Fitch rates Molson loan, notes, convertibles BBB
|
| 4/26/2012 | CACVIG | Moody's rates Molson Coors Brewing bonds Baa2
|
| 4/16/2012 | CACVIG | DBRS downgrades Molson Coors
|
| 4/11/2012 | CV | Market Commentary: New DFC Global rises to 104 on debut; new Prospect reoffered at 97.75; Micron launches
|
| 4/4/2012 | CACVIG | S&P: Molson Coors to negative
|
| 4/3/2012 | CACVIG | Moody's downgrades Coors
|
| 4/3/2012 | CACVIG | Fitch rates Molson Coors loans, notes BBB
|
| 4/3/2012 | CACVIG | DBRS reviews Molson Coors
|
| 4/3/2012 | CV | Market Commentary: Intel, Xilinx active, weaker as broader market reacts to FOMC minutes; Theravance better
|
| 11/4/2011 | CACVIG | S&P: Molson Coors positive
|
| 7/19/2011 | CV | Moody's ups Molson
|
| 5/19/2011 | CV | Market Commentary: Amgen active around 101; Molson Coors, Lam Research trade at steady pricing; WebMD adds
|
| 4/6/2011 | CACV | DBRS affirms Molson
|
| 12/23/2010 | CV | Market Commentary: Convertibles quiet; Navistar sees low print after earnings; Medtronic firmer; GM flat
|
| 9/30/2010 | CACVIG | S&P rates Molson Coors notes BBB-
|
| 9/30/2010 | CACVIG | Moody's rates Molson Coors notes Baa2
|
| 2/19/2010 | CV | DBRS confirms Molson Coors
|
| 5/8/2009 | CVIG | S&P lowers Molson Coors
|
| 7/3/2008 | CVIG | Moody's affirms Molson Coors; outlook positive
|
| 6/24/2008 | CV | Market Commentary: GM, Ford lower despite higher stocks; Coal names in trade; Molson Coors, Virgin Media down
|
| 6/12/2008 | CV | Market Commentary: KeyCorp deal eyed ahead of pricing; Lehman active; Coors slips on rival's buyout news; Invitrogen in line
|
| 1/7/2008 | CV | Pitfalls ahead, but convertibles expected to perform well in 2008, Lehman report says
|
| 11/6/2007 | CV | Market Commentary: iStar surges despite gloomy outlook; ADM up on food sales; CompuCredit crunched; Royal Gold glitters
|
| 11/1/2007 | CV | Market Commentary: Successful test spurs United Therapeutics; iStar, Countrywide down with financials; tough day for four new issues
|
| 10/22/2007 | CV | Market Commentary: Halliburton gushes; Intel rises; AMD, Micron sink; Medtronic slide continues; new offerings power SanDisk
|
| 10/10/2007 | CV | Market Commentary: Molson Coors continues hot streak; Countrywide edges up; ISIS, Level 3 fall; Rayonier, iStar set to play
|
| 10/10/2007 | CVIG | Moody's: Molson Coors view developing
|
| 10/9/2007 | CV | Market Commentary: Molson Coors tap opens; Yahoo! up with rivals soaring; Intel, AMD avoid fall; two more REITs to enter market
|
| 10/9/2007 | CVIG | S&P: SABMiller, Molson Coors unchanged
|
| 9/28/2007 | CV | Market Commentary: Omnicare up on takeover rumors; GM up as contract details emerge; hopes rise for fourth quarter
|
| 9/25/2007 | CV | Market Commentary: USEC hot, Standard Pacific not; GM, Ford bonds feel strike effect; REITs hurt by housing slump
|
| 9/17/2007 | CV | Market Commentary: Baseline prices; USEC talk seeps out; American Tower, Ford up with analysts' thumbs; Fed watch on
|
| 9/12/2007 | CV | Molson Coors convertibles may have run dry, Lehman Brothers report says
|
| 9/12/2007 | CV | Market Commentary: Countrywide holds steady; XM up on merger speculation; Calpine rocked some more; usual suspects rounded up
|
| 9/7/2007 | CV | Market Commentary: Ford, AMD down; Molson Coors moves up; Peabody spins wheels; market meltdown slows movement
|
| 9/6/2007 | CV | Market Commentary: EDO's new device ups convertibles, stock; Diodes, Intel, AMD all up a bit; Molson Coors slips
|
| 9/4/2007 | CV | Market Commentary: Techs, led by Yahoo!, Intel, gain; Molson Coors gains; Vornado slips; trading still stalled
|
| 8/27/2007 | CV | Market Commentary: Gateway surges; Countrywide slides; Molson up; Intel down; markets languid
|
| 7/13/2007 | CV | Market Commentary: Newmont rides metals frenzy; SonoSite up, but Kendle down; Stanley Works active
|
| 7/12/2007 | CV | Market Commentary: Newmont strikes gold; Kendle continues strong; Molson Coors seen refreshing; Huntsman drops a peg
|
| 7/3/2007 | CV | Market Commentary: Ford convertible drives on; CVRD moves up on merger news; Coors brews up interest
|
| 6/26/2007 | CV | Market Commentary: Gannett jumbo deal, GSI issue on tap; Huntsman surges on merger; Amgen slides; Medtronic rises
|
| 6/15/2007 | CV | Molson greenshoe fully exercised on 2.5% convertibles, ups total to $575 million
|
| 6/12/2007 | CV | New Issue: Molson Coors prices $500 million six-year convertibles within talk to yield 2.5%, up 25%
|
| 6/12/2007 | CV | Market Commentary: Molson Coors climbs on debut; NorthStar prices at cheaps; Sunstone quiet in gray; Trex sees no borrow
|
| 6/11/2007 | CV | S&P gives Molson Coors convertibles BBB
|
| 6/11/2007 | CV | Market Commentary: MannKind takes off; Molson quiet in gray; Human Genome rebounds; three REITs, Trex launch deals
|
| 6/11/2007 | CV | Molson Coors talks $500 million six-year convertibles at 2.375%-2.875%, up 22.5%-27.5%
|
